(Q34605658)

3 August 2017

1 reference

title

New trends in Clostridium difficile virulence and pathogenesis (English)

1 reference

3 August 2017

0 references

Clostridium difficile

0 references

author name string

C Denève

1

1 reference

3 August 2017

C Janoir

2

1 reference

3 August 2017

I Poilane

3

1 reference

3 August 2017

C Fantinato

4

1 reference

3 August 2017

A Collignon

5

1 reference

3 August 2017

publication date

1 March 2009

1 reference

International Journal of Antimicrobial Agents

3 August 2017

published in

1 reference

3 August 2017

volume

33 Suppl 1

1 reference

3 August 2017

page(s)

S24-8

1 reference

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Effect of amoxicillin-clavulanic acid on human fecal flora in a gnotobiotic mouse model assessed with fluorescence hybridization using group-specific 16S rRNA probes in combination with flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Nosocomial acquisition of Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Binding of Clostridium difficile to Caco-2 epithelial cell line and to extracellular matrix proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Molecular characterization of the surface layer proteins from Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Characterization of surface layer proteins from different Clostridium difficile clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Characterization of a cell surface protein of Clostridium difficile with adhesive properties

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

GroEL (Hsp60) of Clostridium difficile is involved in cell adherence.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Identification and characterization of a fibronectin-binding protein from Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Transcription and analysis of polymorphism in a cluster of genes encoding surface-associated proteins of Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Clostridium difficile toxin synthesis is negatively regulated by TcdC.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Environmental response and autoregulation of Clostridium difficile TxeR, a sigma factor for toxin gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Regulation of toxin and bacteriocin synthesis in Clostridium species by a new subgroup of RNA polymerase sigma-factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Clostridium difficile toxin expression is inhibited by the novel regulator TcdC

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Frequency of Binary Toxin Genes among Clostridium difficile Strains That Do Not Produce Large Clostridial Toxins

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

An epidemic, toxin gene-variant strain of Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Update on the changing epidemiology of Clostridium difficile-associated disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-rep

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970012-3

7 January 2021

10.1016/S0924-8579(09)70012-3

Identifiers

DOI

1 reference

3 August 2017

1 reference